Results 11 to 20 of about 195,338 (284)

GM-CSF: A Double-Edged Sword in Cancer Immunotherapy

open access: yesFrontiers in Immunology, 2022
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that drives the generation of myeloid cell subsets including neutrophils, monocytes, macrophages, and dendritic cells in response to stress, infections, and cancers.
Anil Kumar   +4 more
doaj   +1 more source

GM-CSF Primes Proinflammatory Monocyte Responses in Ankylosing Spondylitis

open access: yesFrontiers in Immunology, 2020
Objectives: GM-CSF is a pro-inflammatory cytokine with multiple actions predominantly on myeloid cells. Enhanced GM-CSF expression by lymphocytes from patients with Ankylosing Spondylitis (AS) has recently been described, however, its potential ...
Hui Shi   +7 more
doaj   +1 more source

Generation and utilization of a HEK-293T murine GM-CSF expressing cell line.

open access: yesPLoS ONE, 2021
Macrophages and dendritic cells (DCs) are innate immune cells that play a key role in defense against pathogens. In vitro cultures of bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs) are well-established and valuable methods for ...
Elektra Kantzari Robinson   +3 more
doaj   +1 more source

Role of Granulocyte-Macrophage Colony-Stimulating Factor Production by T Cells during Mycobacterium tuberculosis Infection

open access: yesmBio, 2017
Mice deficient for granulocyte-macrophage colony-stimulating factor (GM-CSF−/−) are highly susceptible to infection with Mycobacterium tuberculosis, and clinical data have shown that anti-GM-CSF neutralizing antibodies can lead to increased ...
Alissa C. Rothchild   +10 more
doaj   +1 more source

Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells [PDF]

open access: yes, 2004
The granulocyte-macrophage colony-stimulating factor (GM-CSF) analog E21R binds to the GM-CSF receptor complex with low affinity and acts as a competitive antagonist.
Grandage, V.L.   +3 more
core   +1 more source

Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses

open access: yesRespiratory Research, 2018
Background Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare pulmonary disease caused by functional deficiency of granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF therapy in aPAP has been reported effective in some studies. This
Gaohong Sheng   +5 more
doaj   +1 more source

Determinants of a transcriptionally competent environment at the GM-CSF promoter [PDF]

open access: yes, 2015
Granulocyte macrophage-colony stimulating factor (GM-CSF) is produced by T cells, but not B cells, in response to immune signals. GM-CSF gene activation in response to T-cell stimulation requires remodelling of chromatin associated with the gene ...
Brettingham-Moore, Kate H   +5 more
core   +1 more source

GM-CSF signalling boosts dramatically IL-1 production. [PDF]

open access: yesPLoS ONE, 2011
GM-CSF is mostly known for its capacity to promote bone marrow progenitor differentiation, to mobilize and mature myeloid cells as well as to enhance host immune responses. However the molecular actions of GM-CSF are still poorly characterized.
Hanif Javanmard Khameneh   +4 more
doaj   +1 more source

Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update. [PDF]

open access: yes, 2019
Granulocyte-macrophage colony-stimulating factor (GM-CSF) was first described as a growth factor that induces the differentiation and proliferation of myeloid progenitors in the bone marrow.
Adorini   +134 more
core   +2 more sources

GM-CSF in murine psoriasiform dermatitis: Redundant and pathogenic roles uncovered by antibody-induced neutralization and genetic deficiency.

open access: yesPLoS ONE, 2017
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic, Th17-derived cytokine thought to critically contribute to the pathogenesis of diverse autoimmune diseases, including rheumatoid arthritis and psoriasis. Treatment with monoclonal
Tatjana Scholz   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy